If you have been watching Morgan Stanley recently, you are not alone. With many investors trying to figure out whether now is the right time to buy, hold, or cash out, the conversation has gotten interesting. Over the past five years, Morgan Stanley’s stock has soared an incredible 266.8%, and in just the past twelve months, jumped another 63.9%. Even more impressive, just this year, the shares have surged 25.3% already, catching the eye of both growth-minded investors and those seeking stability.

So, what is behind the recent uptick? Much of the upward momentum is driven by broader optimism in financial markets, especially as investors respond to shifting inflation expectations and a steady appetite for advisory services. These forces have made financial stocks like Morgan Stanley more attractive, pushing the price to a recent close of $156.39 and lifting its profile among Wall Street analysts.

But let’s get real. Strong price performance can attract enthusiasm, but it can also raise questions about whether the stock is still undervalued or has become too pricey. Using established valuation checks, Morgan Stanley currently scores a 3 out of 6, indicating it is undervalued by some standards but not across the board.

In the next section, we will break down the key valuation approaches for Morgan Stanley, helping you see where it shines and where caution is warranted. Stick around, because we will also explore a fresh angle that could offer a better framework for understanding just how undervalued or overvalued this bank might be.

Morgan Stanley delivered 63.9% returns over the last year. See how this stacks up to the rest of the Capital Markets industry.

The Excess Returns model is used to gauge a company's ability to generate returns above its cost of equity. This model focuses on how effectively a company reinvests capital and grows shareholder value. It is particularly useful when analyzing financial stocks, where stable profits and prudent capital allocation often drive value.

Several key figures stand out for Morgan Stanley. The book value is $61.59 per share, and the average return on equity is 14.97%. Analysts project a stable EPS of $9.84 per share, calculated from future return on equity estimates by 12 analysts. When compared to the calculated cost of equity of $6.41 per share, this results in an excess return of $3.43 per share. The stable book value is also estimated at $65.73 per share, based on consensus among 14 analysts.

Using these inputs, the Excess Returns model estimates an intrinsic value for Morgan Stanley of $117.19 per share. With the current market price at $156.39, this valuation suggests the stock is approximately 33.5% overvalued at this time. While the company's profitability is healthy, the price appears well ahead of fundamentals when assessed with this model.

Result: OVERVALUED

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Morgan Stanley.

Our Excess Returns analysis suggests Morgan Stanley may be overvalued by 33.5%. Find undervalued stocks or create your own screener to find better value opportunities.

The Price-to-Earnings (PE) ratio is widely regarded as an effective valuation tool for profitable companies like Morgan Stanley. This metric allows investors to quickly gauge how much the market is willing to pay for each dollar of current earnings, making it especially useful when the company has stable, positive profits and predictable growth streams.

The "fair" PE ratio for a stock is not a fixed figure. It tends to move higher for companies with stronger growth prospects and lower risk, and contracts for those facing uncertainty. Morgan Stanley currently trades at a PE ratio of 17.7x. That is notably below the Capital Markets industry average of 27.2x and its peer group’s average of 33.2x, suggesting the stock appears cheap on a traditional comparison basis.

However, Simply Wall St’s proprietary Fair Ratio model refines this analysis. The Fair Ratio for Morgan Stanley is calculated at 20.1x, which considers not just industry norms but also the bank’s earnings growth, risk profile, profitability, and market cap. This tailored benchmark offers a more complete valuation context compared with simple peer or industry averages.

Since the company’s actual PE ratio of 17.7x is only slightly below its Fair Ratio of 20.1x, Morgan Stanley’s shares appear to be priced about right at today’s levels.

Result: ABOUT RIGHT

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover companies where insiders are betting big on explosive growth.

Earlier we mentioned there is an even better way to understand valuation, so let’s introduce you to Narratives. A Narrative is a simple but powerful tool that lets you shape your view of a company’s future by telling the story behind the numbers. It connects your assumptions about growth, margins, and risks to a forecast and then to a fair value. Narratives make investment decisions more intuitive by linking what’s happening in the business to a dynamic valuation, helping you cut through market noise and focus on what really matters.

Available on Simply Wall St’s Community page and used by millions of investors, Narratives are easy to build and compare. They empower you to see where your assumptions line up (or differ) from the crowd and to decide whether the stock looks like a buy or a sell by comparing the Fair Value from your story to today's actual price. When news or financial updates arrive, Narratives update automatically so you always see the most relevant outlook for Morgan Stanley.

For example, some investors currently see a bright future for Morgan Stanley and assign a fair value as high as $160.00, while others take a more cautious view, arriving at just $122.00. Your own Narrative could fall anywhere in between.

Do you think there's more to the story for Morgan Stanley? Create your own Narrative to let the Community know!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include MS.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com